Accurate, auditable records for HPLC mobile-phase expiry decisions ensure that every decision to set, extend, or close an expiry or in-use interval is supported by provenance, analytical evidence, and reviewer rationale. This article focuses on the lifecycle evidence required to justify expiry or use-by decisions and the closure entries that complete each record.
Preparation provenance and record components
Each mobile-phase batch record should capture preparation provenance: preparer identity, date and time of preparation, lot numbers of components, measured volumes or masses, pH or composition checks at preparation, and storage location. Retain the original preparation worksheet or electronic entry and link it to any intermediate labels or transfer records used during sequence loading. Provenance entries must include instrument or balance identifications used for measurement and any deviations from the standard recipe, with rationale recorded.
Stability evidence and expiry rationale
Expiry decisions should be based on documented stability evidence applicable to the specific formulation and storage condition. Typical supporting evidence includes trending of pH, visual clarity, system performance checks (for example, impact on retention time or peak shape), and any short-term impurity increase detected by an appropriate analytical method. Where applicable, reference to relevant quality guidelines and manufacturing practice expectations provides context for the quality of records and retention timelines — for example, regulatory records guidance and GMP practice documents offer record-keeping expectations and retention logic as a framework for documenting expiry rationale.
When analytical data are used to justify an expiry interval, include the raw data file references, method version, system suitability results contemporaneous with the samples, and an explicit statement that links the observed analytical stability to the chosen expiry. If conservative time limits are used in the absence of long-term data, document the justification and the conditions under which an extension may be sought.
In-use sequence, partial-use handling, and conditional disposition
Records must show how a prepared mobile phase was introduced into an HPLC sequence and any in-use time accrued. If a mobile phase is partially consumed and returned to storage, record the amount removed, the line of custody, and whether the remaining volume remains under the original batch label. Define and document conditional rules for partial-use: for example, maximum allowed time at ambient conditions, allowable transfer between vessels, and re-assessment triggers (visual change, pH drift, abnormal system suitability). Each conditional disposition action — extend, quarantine, re-test, or discard — requires a documented decision with supporting data and reviewer signature.
Review, sign-off, and audit trail requirements
Every expiry decision record should include a reviewer assessment that references the specific evidence reviewed, the rationale for the decision, and any follow-up actions. The review entry must identify the reviewer, the date of review, and the decision outcome (approve, reject, require additional data). Maintain an unalterable audit trail for electronic records or a clear crossing-out and initialing convention for hard-copy records. Periodic review of retained mobile-phase records helps identify trends that could justify procedural changes or different shelf-life controls.
For institutional guidance and record expectations consult regulatory and good-practice documents that address records, retention, and data integrity. See the FDA current good manufacturing practice records and reports Q&A for record expectations: FDA Q&A on cGMP records and reports. For manufacturing and analytical practice context refer to the ICH Q7 GMP guideline for pharmaceutical starting materials and documentation principles: ICH Q7 GMP Guideline.
When closing a mobile-phase batch record, include the final disposition entry (released for use with expiry, released with conditions, or discarded), the supporting evidence summary, and final sign-off. Proper closure completes the chain of custody, preserves traceability back to components and instruments, and provides a defensible rationale for audit or investigation.
Not for human consumption. For laboratory research use only.